在ALS和SMA-A前性观察性研究中脂肪和体代谢的改变
C Herrmann1, Z Uzelac1, S Michels1
1Department of Neurology, University of Ulm, Ulm, Germany.
European journal of neurology
|April 9, 2025
概括
这项研究揭示了肌缩性侧面硬化 (ALS) 和脊髓肌缩 (SMA) 的明显代谢变化,在这两种疾病中都观察到较高的体. 这些发现表明体是这些运动神经元疾病的潜在治疗点.
科学领域:
- 神经学 神经学
- 代谢研究研究 代谢研究
- 生物化学 生化学
背景情况:
- 肌缩侧面硬化 (ALS) 和脊髓肌缩 (SMA) 是运动神经元疾病,其特点是显著的代谢变化.
- 增加的休息能量消耗 (REE) 和体重减轻在ALS中很常见,而SMA涉及脂肪酸利用能力受损.
- 这些代谢障碍会对患者的预后产生负面影响,强调需要进一步调查.
研究的目的:
- 为了全面描述ALS和SMA患者的代谢变化.
- 通过分析脂肪和子代谢来确定潜在的治疗点.
- 为了比较ALS,SMA和健康对照之间的代谢概况.
主要方法:
- 在2020年11月至2022年8月期间招募了112名ALS患者,77名SMA患者和50名对照人群.
- 收集标准化血液和尿液样本进行分析.
- 分析的重点是脂肪代谢和体生产.
主要成果:
- 与对照人群相比,在ALS和SMA患者中检测到体水平升高.
- 在ALS和SMA中,较高的体重指数 (BMI) 与增加的体和自由脂肪酸相关,与对照组不同.
- 更严重的SMA疾病类型显示了更高的体水平,SMA患者的体和自由脂肪酸水平比ALS患者更高.
结论:
- 患有ALS的患者在疾病早期似乎会产生体,以弥补能量不足.
- 在SMA中,持续的生成可能表明由于脂肪酸代谢问题,能量生产途径的补偿上调.
- 补充体是一种有前途的治疗策略,用于ALS和SMA.
更多相关视频
06:49A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
Published on: October 6, 2015
19.5K
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
11.6K
相关概念视频
Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
